ATLANTA, August 22, 2026, 10:55 EDT
- KO rose 3.9% last week and closed Friday at $91.10.
- The shares ended only 3.9% below the $94.70 analyst-consensus target.
- Coca-Cola raised its 2026 organic-sales and comparable-EPS outlook in July.
- U.S. consumption and inflation data arrive Wednesday, when the valuation premium faces its next test.
The Coca-Cola Company NYSE:KO ended Friday at $91.10, gaining 3.9% for the week. That rally left the shares near their 52-week high and narrowed the gap to Wall Street’s average target to just 3.9%.
The move changes the near-term investment case. Coca-Cola’s stronger earnings outlook is now well recognized, while the price leaves less room for ordinary execution.
| Date | Close | Daily move |
|---|---|---|
| Aug. 17 | $86.98 | -0.83% |
| Aug. 18 | $88.82 | +2.12% |
| Aug. 19 | $90.35 | +1.72% |
| Aug. 20 | $90.50 | +0.17% |
| Aug. 21 | $91.10 | +0.66% |
Friday’s advance came with a broader rebound. The S&P 500 rose 0.43%, while Coca-Cola gained 0.66%. PepsiCo, Inc. NASDAQ:PEP added 0.99%, and Keurig Dr Pepper Inc. NASDAQ:KDP rose 1.20%.
The valuation gap is substantial. Calculations based on Friday’s closes and the latest trailing earnings show Coca-Cola at roughly 27.4 times earnings. PepsiCo trades near 18.8 times, though its snack exposure makes the comparison imperfect.
| Company | Friday close | Approx. trailing P/E | Indicated yield |
|---|---|---|---|
| Coca-Cola NYSE:KO | $91.10 | 27.4x | 2.3% |
| PepsiCo NASDAQ:PEP | $143.48 | 18.8x | 4.1% |
| Keurig Dr Pepper NASDAQ:KDP | $32.04 | 32.4x | 2.9% |
That premium has operating support. Coca-Cola’s second-quarter revenue rose 7% to $13.4 billion. Organic revenue increased 6%, while global unit-case volume gained 5%.
Comparable earnings per share climbed 11% to $0.97. Comparable operating margin expanded to 35.6% from 34.7%, despite higher input costs and marketing spending.
| 2026 measure | Current outlook | Previous outlook |
|---|---|---|
| Organic revenue growth | About 5% | 4% to 5% |
| Comparable EPS growth | 9% to 10% | 8% to 9% |
| Free cash flow | About $12.4 billion | About $12.2 billion |
| Currency effect on comparable EPS | About 3-point tailwind | About 3-point tailwind |
Chief Executive Henrique Braun said the company had delivered a strong quarter by staying close to changing consumer and customer needs. The result included 3% North American volume growth and 4% price/mix.
Still, the latest price sits close to several published targets. The $94.70 consensus implies only $3.60 per share of upside from Friday’s close.
| Analyst or consensus | View | Target | Upside/downside from $91.10 |
|---|---|---|---|
| Three-month consensus | 19 Buy / 4 Hold / 1 Sell | $94.70 | +3.9% |
| UBS | Buy | $104 | +14.2% |
| Piper Sandler | Overweight | $95 | +4.3% |
| Bernstein SocGen | Market Perform | $93 | +2.1% |
| BofA Securities | Underperform | $95 | +4.3% |
The target spread matters more after a fast rally. UBS’s $104 target still offers double-digit potential. Bernstein’s $93 target leaves barely 2%.
The next market test arrives Wednesday. U.S. personal-income, spending and PCE inflation data are due at 08:30 EDT, alongside the second estimate of second-quarter GDP.
Those releases can shift bond yields and defensive-stock multiples. Coca-Cola’s low beta has helped its appeal, but a higher-rate path can pressure premium valuations.
Risks: Input-cost inflation, weaker consumer demand, adverse currency moves and execution on bottling refranchising could reduce earnings. Better volume or currency trends could instead justify a higher target range.
For next week, the key number is $94.70. A sustained move toward that level would leave investors relying more on target upgrades than on the existing consensus.


